171 related articles for article (PubMed ID: 36203415)
1. Evaluation of colorectal cancer liver metastases based on liquid biopsy combined with folate receptor- Positive circulating tumor cells and HSP90.
Huang M; Cheng L; Mo S; Ru H; Mo X; Yan L
Front Oncol; 2022; 12():912016. PubMed ID: 36203415
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study.
Wei ZJ; Zhou BC; Wang GX; Han WX; Li YX; Xu AM
Int J Clin Oncol; 2024 Feb; 29(2):149-158. PubMed ID: 38112831
[TBL] [Abstract][Full Text] [Related]
3. The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study.
Yan S; Guo W; Liu Y; Li K; Wang W
Int J Clin Oncol; 2022 Mar; 27(3):538-544. PubMed ID: 35043284
[TBL] [Abstract][Full Text] [Related]
4. Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer.
Cheng H; Yang J; Fu X; Mao L; Chu X; Lu C; Li G; Qiu Y; He W
Front Oncol; 2022; 12():1012609. PubMed ID: 36313690
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach.
Ning Y; Hanna DL; Zhang W; Mendez A; Yang D; El-Khoueiry R; Matsusaka S; Sunakawa Y; Stremitzer S; Parekh A; Okazaki S; Berger MD; Barzi A; Lenz HJ
Mol Cancer Ther; 2015 Oct; 14(10):2401-8. PubMed ID: 26227487
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Folate Receptor-Positive Circulating Tumor Cells Are Associated With Occult Peritoneal Metastasis and Early Recurrence in Gastric Cancer Patients: A Prospective Cohort Study.
Zeng CDD; Jin CC; Gao C; Xiao AT; Tong YX; Zhang S
Front Oncol; 2022; 12():769203. PubMed ID: 35425708
[TBL] [Abstract][Full Text] [Related]
7. Folate receptor-positive circulating tumor cells in predicting ground-glass nodules malignancy.
Yue YS; Sun ZH; Cui Q; Jiang GZ
Am J Transl Res; 2023; 15(4):2828-2835. PubMed ID: 37193191
[TBL] [Abstract][Full Text] [Related]
8. The combination of folate receptor-positive circulating tumor cells and serum tumor markers suggests a histological diagnosis of lung cancer.
Lv X; Wu S; Xu X; Wu L; Chang N; Zhang J; Ti X
J Thorac Dis; 2022 Jan; 14(1):158-168. PubMed ID: 35242377
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients.
Li H; Li B; Pan Y; Zhang Y; Xiang J; Zhang Y; Sun Y; Yu X; He W; Hu H
Front Oncol; 2020; 10():621435. PubMed ID: 33585249
[TBL] [Abstract][Full Text] [Related]
10. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics.
Xu Y; Li Q; Lin Z; Lin Y
Clin Respir J; 2023 May; 17(5):374-383. PubMed ID: 36977421
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
12. Clinico-pathological correlation of serial measurement of circulating tumor cells in 24 metastatic colorectal cancer patients receiving chemotherapy reveals interpatient heterogeneity correlated with CEA levels but independent of KRAS and BRAF mutation.
Das A; Kunkel M; Joudeh J; Dicker DT; Scicchitano A; Allen JE; Sarwani N; Yang Z; Kaifi J; Zhu J; Liao J; El-Deiry WS
Cancer Biol Ther; 2015; 16(5):709-13. PubMed ID: 25806877
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of circulating tumour cells and tumour marker detection in the chemotherapeutic evaluation of advanced colorectal cancer.
Shen F; Zhu Y; Wang F; Cai X; Ding H; Zhou F; Wang J; Gu H; Liu C; Li Q
Colorectal Dis; 2022 Jan; 24(1):68-76. PubMed ID: 34611964
[TBL] [Abstract][Full Text] [Related]
14. Circulating Tumor Cells in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Clinical Utility for Long-Term Outcome: A Prospective Trial.
Arrazubi V; Mata E; Antelo ML; Tarifa A; Herrera J; Zazpe C; Teijeira L; Viudez A; Suárez J; Hernández I; Vera R
Ann Surg Oncol; 2019 Sep; 26(9):2805-2811. PubMed ID: 31209673
[TBL] [Abstract][Full Text] [Related]
15. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.
Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R
Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533
[TBL] [Abstract][Full Text] [Related]
16. Validation of the diagnostic efficiency of folate receptor-positive circulating tumor cells in lung cancers: a prospective observational study.
Liu J; Han M; Huang H
Transl Cancer Res; 2019 Aug; 8(4):1242-1248. PubMed ID: 35116866
[TBL] [Abstract][Full Text] [Related]
17. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
[TBL] [Abstract][Full Text] [Related]
18. Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse.
Wang H; Liu L; Yan J; Ma W; Du Y; Zhang T
Front Oncol; 2022; 12():1097816. PubMed ID: 36741689
[TBL] [Abstract][Full Text] [Related]
19. The utility of folate receptor-positive circulating tumor cell in cancer diagnosis in the elderly population.
Li N; Zhong D; Chen H; Huang T; Hou P; Zhang Y; Chen F; Wang X; Zhang H
Cancer Manag Res; 2019; 11():4097-4107. PubMed ID: 31190982
[No Abstract] [Full Text] [Related]
20. Preoperative levels of folate receptor-positive circulating tumor cells in different subtypes of early-stage lung adenocarcinoma: Predictive value for determining extent of surgical resection.
Zhou C; Zhao R; Zhao R; Wang A; Li W
Front Oncol; 2023; 13():1119807. PubMed ID: 37139152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
